Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Zidovudine use in pregnancy and congenital malformations.

Rough K, Sun JW, Seage GR 3rd, Williams PL, Huybrechts KF, Bateman BT, Hernandez-Diaz S.

AIDS. 2017 Jul 31;31(12):1733-1743. doi: 10.1097/QAD.0000000000001549.

PMID:
28537936
2.

The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs.

Van Dyke RB, Chadwick EG, Hazra R, Williams PL, Seage GR 3rd.

Front Immunol. 2016 May 23;7:199. doi: 10.3389/fimmu.2016.00199. eCollection 2016. Review.

3.

EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.

Given JE, Loane M, Luteijn JM, Morris JK, de Jong van den Berg LT, Garne E, Addor MC, Barisic I, de Walle H, Gatt M, Klungsoyr K, Khoshnood B, Latos-Bielenska A, Nelen V, Neville AJ, O'Mahony M, Pierini A, Tucker D, Wiesel A, Dolk H.

Br J Clin Pharmacol. 2016 Oct;82(4):1094-109. doi: 10.1111/bcp.12947. Epub 2016 Jul 7.

4.

Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.

Prieto LM, González-Tomé MI, Muñoz E, Fernández-Ibieta M, Soto B, Álvarez A, Navarro ML, Roa MÁ, Beceiro J, de José MI, Olabarrieta I, Lora D, Ramos JT; Madrid Cohort of HIV-Infected Mother-Infant Pairs.

BMC Infect Dis. 2014 Dec 24;14:700. doi: 10.1186/s12879-014-0700-3.

5.

Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.

Williams PL, Crain MJ, Yildirim C, Hazra R, Van Dyke RB, Rich K, Read JS, Stuard E, Rathore M, Mendez HA, Watts DH; Pediatric HIV/AIDS Cohort Study.

JAMA Pediatr. 2015 Jan;169(1):48-55. doi: 10.1001/jamapediatrics.2014.1889.

6.

First trimester exposure to antiretroviral therapy and risk of birth defects.

Phiri K, Hernandez-Diaz S, Dugan KB, Williams PL, Dudley JA, Jules A, Callahan ST, Seage GR 3rd, Cooper WO.

Pediatr Infect Dis J. 2014 Jul;33(7):741-6. doi: 10.1097/INF.0000000000000251.

7.

Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.

Prestes-Carneiro LE.

HIV AIDS (Auckl). 2013 Aug 1;5:181-9. doi: 10.2147/HIV.S15542. eCollection 2013.

8.

Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Read JS, Huo Y, Patel K, Mitchell M, Scott GB.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):92-102. doi: 10.1093/jpids/pis036. Epub 2012 May 3.

9.

Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.

Knapp KM, Brogly SB, Muenz DG, Spiegel HM, Conway DH, Scott GB, Talbot JT, Shapiro DE, Read JS.

Pediatr Infect Dis J. 2012 Feb;31(2):164-70. doi: 10.1097/INF.0b013e318235c7aa.

10.

Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.

Watts DH, Huang S, Culnane M, Kaiser KA, Scheuerle A, Mofenson L, Stanley K, Newell ML, Mandelbrot L, Delfraissy JF, Cunningham CK.

J Perinat Med. 2011 Mar;39(2):163-70. doi: 10.1515/JPM.2010.139. Epub 2010 Dec 13.

11.

Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.

Brogly SB, Abzug MJ, Watts DH, Cunningham CK, Williams PL, Oleske J, Conway D, Sperling RS, Spiegel H, Van Dyke RB.

Pediatr Infect Dis J. 2010 Aug;29(8):721-7. doi: 10.1097/INF.0b013e3181e74a2f.

12.

Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.

Joao EC, Calvet GA, Krauss MR, Freimanis Hance L, Ortiz J, Ivalo SA, Pierre R, Reyes M, Heather Watts D, Read JS; NISDI Perinatal Study Group.

J Acquir Immune Defic Syndr. 2010 Feb;53(2):176-85. doi: 10.1097/QAI.0b013e3181c5c81f.

Supplemental Content

Support Center